These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 19076962)

  • 21. Magnetic resonance spectroscopy of the breast: current status.
    Bolan PJ
    Magn Reson Imaging Clin N Am; 2013 Aug; 21(3):625-39. PubMed ID: 23928249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic characterization of primary and metastatic ovarian cancer by 1H-MRS in vivo at 3T.
    McLean MA; Priest AN; Joubert I; Lomas DJ; Kataoka MY; Earl H; Crawford R; Brenton JD; Griffiths JR; Sala E
    Magn Reson Med; 2009 Oct; 62(4):855-61. PubMed ID: 19645005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative multivoxel proton chemical shift imaging of the breast.
    Sijens PE; Dorrius MD; Kappert P; Baron P; Pijnappel RM; Oudkerk M
    Magn Reson Imaging; 2010 Apr; 28(3):314-9. PubMed ID: 20071119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer.
    Jagannathan NR; Kumar M; Seenu V; Coshic O; Dwivedi SN; Julka PK; Srivastava A; Rath GK
    Br J Cancer; 2001 Apr; 84(8):1016-22. PubMed ID: 11308247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are you missing gynaecological cancers at the early stage?
    Piver MS
    Mod Med Asia; 1978 Dec; 14(12):9-12. PubMed ID: 750909
    [No Abstract]   [Full Text] [Related]  

  • 26. In vivo proton spectroscopy of giant cell tumor of the bone.
    Sah PL; Sharma R; Kandpal H; Seith A; Rastogi S; Bandhu S; Jagannathan NR
    AJR Am J Roentgenol; 2008 Feb; 190(2):W133-9. PubMed ID: 18212197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic changes in pelvic lesions: findings at proton MR spectroscopic imaging.
    Hascalik S; Celik O; Sarac K; Meydanli MM; Alkan A; Mizrak B
    Gynecol Obstet Invest; 2005; 60(3):121-7. PubMed ID: 15920339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of musculoskeletal lesions on 3-T proton MR spectroscopy.
    Fayad LM; Barker PB; Jacobs MA; Eng J; Weber KL; Kulesza P; Bluemke DA
    AJR Am J Roentgenol; 2007 Jun; 188(6):1513-20. PubMed ID: 17515370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Gynaecological and breast cancers at the Dakar Cancer Institute].
    Dem A; Traoré B; Dieng MM; Diop PS; Ouajdi T; Lalami MT; Diop M; Dangou JM; Touré P
    Sante; 2008; 18(1):25-9. PubMed ID: 18684687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Localized nuclear magnetic resonance spectroscopy in vivo. Physical principles and quantitative problems].
    Canese R; Podo F
    Ann Ist Super Sanita; 1991; 27(4):675-708. PubMed ID: 1820740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigation of breast cancer using two-dimensional MRS.
    Thomas MA; Lipnick S; Velan SS; Liu X; Banakar S; Binesh N; Ramadan S; Ambrosio A; Raylman RR; Sayre J; DeBruhl N; Bassett L
    NMR Biomed; 2009 Jan; 22(1):77-91. PubMed ID: 19086016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proton MR spectroscopy of the breast.
    Tozaki M
    Breast Cancer; 2008; 15(3):218-23. PubMed ID: 18443899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo proton MR spectroscopy of the breast using the total choline peak integral as a marker of malignancy.
    Sardanelli F; Fausto A; Di Leo G; de Nijs R; Vorbuchner M; Podo F
    AJR Am J Roentgenol; 2009 Jun; 192(6):1608-17. PubMed ID: 19457825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synchronous endometrial and cervical tumors in a 26-year-old nullipara: diagnostic modalities updated.
    Hascalik S; Celik O; Erdem G; Usta U; Alkan A; Karakas HM; Mizrak B
    Gynecol Obstet Invest; 2005; 60(3):171-6. PubMed ID: 15995344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Noninvasive monitoring of radiation-induced treatment response using proton magnetic resonance spectroscopy and diffusion-weighted magnetic resonance imaging in a colorectal tumor model.
    Seierstad T; Røe K; Olsen DR
    Radiother Oncol; 2007 Nov; 85(2):187-94. PubMed ID: 17937968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular characterization of musculoskeletal tumors by proton MR spectroscopy.
    Fayad LM; Barker PB; Bluemke DA
    Semin Musculoskelet Radiol; 2007 Sep; 11(3):240-5. PubMed ID: 18260034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biochemical alterations from normal mucosa to gastric cancer by ex vivo magnetic resonance spectroscopy.
    Calabrese C; Pisi A; Di Febo G; Liguori G; Filippini G; Cervellera M; Righi V; Lucchi P; Mucci A; Schenetti L; Tonini V; Tosi MR; Tugnoli V
    Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1386-95. PubMed ID: 18559553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential use of in vivo proton spectroscopy for head and neck lesions.
    Mafee MF; Bárány M; Gotsis ED; Dobben GD; Puklin J; Chow JM; Wenig BL
    Radiol Clin North Am; 1989 Mar; 27(2):243-54. PubMed ID: 2537499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo characterisation of soft tissue tumours by 1.5-T proton MR spectroscopy.
    Russo F; Mazzetti S; Grignani G; De Rosa G; Aglietta M; Anselmetti GC; Stasi M; Regge D
    Eur Radiol; 2012 May; 22(5):1131-9. PubMed ID: 22138734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MR Spectroscopy for Differentiating Benign From Malignant Solid Adnexal Tumors.
    Ma FH; Qiang JW; Cai SQ; Zhao SH; Zhang GF; Rao YM
    AJR Am J Roentgenol; 2015 Jun; 204(6):W724-30. PubMed ID: 26001263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.